Scott Cheatham: Weight Loss Drugs & Lifestyle

It's been 4 years since Wegovy, the GLP-1 weight loss drug, was first approved by the FDA for weight management. We've learned a lot; but there's still a lot we don't know.  On this week's episode of the “Better Than Fine” podcast, host Darlene Marshall is joined by featured guest, researcher and practitioner, Dr. Scott Cheatham, to take a closer look at how lifestyle impacts the outcomes of modern weight loss drugs. If you like what you just consumed, leave us a 5-star review, and share this episode with a friend to help grow our NASM health and wellness community! The content shared in this podcast is solely for educational and entertainment purposes. It is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek out the guidance of your healthcare provider or other qualified professional. Any opinions expressed by guests and hosts are their own and do not necessarily reflect the views of NASM. Introducing NASM One, the membership for trainers and coaches. For just $35/mo., get unlimited access to over 300 courses, 50% off additional certifications and specializations, EDGE Trainer Pro all-in-one coaching app to grow your business, unlimited exam attempts and select waived fees. Stay on top of your game and ahead of the curve as a fitness professional with NASM One. Click here to learn more. ttps://bit.ly/4ddsgrm